A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma
Status:
Completed
Trial end date:
2020-10-15
Target enrollment:
Participant gender:
Summary
This study aims to show that 3-dimensional PET/CT imaging with a new novel PET tracer (called
[124I]mIBG) can detect as many or more sites of neuroblastoma (a type of childhood cancer)
compared to the recommended 1-dimensional routine scans (called [123I]mIBG planar
scintigraphy).